News

April 24, 2023 /PRNewswire/ -- Boehringer Ingelheim today announced that the U.S. Food and Drug Administration (FDA) has approved the newest addition to its feline portfolio — NexGard ® COMBO ...
Boehringer Ingelheim announced that the US Food and Drug Administration (FDA) has approved the newest innovation from the trusted NexGard Brand of Products — NexGard PLUS (afoxolaner, moxidectin and ...
The NexGard ® COMBO formulation is the latest example of Boehringer Ingelheim building on its history of leadership in animal health to provide advanced, preventive animal healthcare and develop ...